2021 annual financial data
Marker Therapeutics, Inc. 2021 Net margin
Marker Therapeutics, Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was -3,372.68%.
Operating income was -39,477,995 USD and net income was -41,878,871 USD.
Operating cash flow was -27,279,765 USD.
Get free Marker Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,241,710 USD
- Operating income
- -39,477,995 USD
- Net income
- -41,878,871 USD
- Operating cash flow
- -27,279,765 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Marker Therapeutics, Inc. financial years